(Q40516605)

English

Phase II study of temozolomide and cisplatin as primary treatment prior to radiotherapy in newly diagnosed glioblastoma multiforme patients with measurable disease. A study of the Spanish Medical Neuro-Oncology Group (GENOM).

scientific article published on December 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Phase II study of temozolomide and cisplatin as primary treatment prior to radiotherapy in newly diagnosed glioblastoma multiforme patients with measurable disease. A study of the Spanish Medical Neuro-Oncology Group (GENOM). (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

1 reference

based on heuristic

inferred from title

author name string

Carmen Balaña

1

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Antonio López-Pousa

2

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Alfonso Berrocal

3

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Ricardo Yaya-Tur

4

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Ana Herrero

5

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Jose-Luis García

6

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Javier Martín-Broto

7

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Manuel Benavides

8

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Miguel Cerdá-Nicolás

9

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Rosa Ballester

10

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Josep Balart

11

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Jaume Capellades

12

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

publication date

1 December 2004

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Journal of Neuro-Oncology

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

70

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

359-369

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

O6-methyl-guanine-DNA methyltransferase methylation in serum and tumor DNA predicts response to 1,3-bis(2-chloroethyl)-1-nitrosourea but not to temozolamide plus cisplatin in glioblastoma multiforme

1 reference

https://pubmed.ncbi.nlm.nih.gov/15662978

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse

1 reference

https://pubmed.ncbi.nlm.nih.gov/15662978

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

DNA mismatch repair and O6-alkylguanine-DNA alkyltransferase analysis and response to Temodal in newly diagnosed malignant glioma

1 reference

https://pubmed.ncbi.nlm.nih.gov/15662978

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase II study of temozolomide in patients with newly diagnosed supratentorial malignant glioma before radiation therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/15662978

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Marked inactivation of O6-alkylguanine-DNA alkyltransferase activity with protracted temozolomide schedules

1 reference

https://pubmed.ncbi.nlm.nih.gov/15662978

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/15662978

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inactivation of O6-alkylguanine-DNA alkyltransferase in HeLa cells by cisplatin.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15662978

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II trial of carmustine plus O(6)-benzylguanine for patients with nitrosourea-resistant recurrent or progressive malignant glioma

1 reference

https://pubmed.ncbi.nlm.nih.gov/15662978

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of cisplatin in recurrent astrocytomas in adults: A southwest oncology group study

1 reference

https://pubmed.ncbi.nlm.nih.gov/15662978

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Repair of O(6)-alkylguanine by alkyltransferases

1 reference

https://pubmed.ncbi.nlm.nih.gov/15662978

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of recurrent high grade astrocytoma; results of a systematic review of 1,415 patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15662978

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The New Approaches to Brain Tumor Therapy (NABTT) CNS Consortium: Organization, Objectives, and Activities

1 reference

https://pubmed.ncbi.nlm.nih.gov/15662978

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemotherapy for brain tumors of astrocytic and oligodendroglial lineage: the past decade and where we are heading

1 reference

https://pubmed.ncbi.nlm.nih.gov/15662978

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Potentiation of temozolomide and BCNU cytotoxicity by O(6)-benzylguanine: a comparative study in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/15662978

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A Phase I and pharmacokinetic study of temozolomide and cisplatin in patients with advanced solid malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/15662978

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Response criteria for phase II studies of supratentorial malignant glioma

1 reference

https://pubmed.ncbi.nlm.nih.gov/15662978

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Verbally administered Barthel Index as functional assessment in brain tumour patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/15662978

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15662978

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of continuous infusion carmustine and cisplatin followed by cranial irradiation in adults with newly diagnosed high-grade astrocytoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15662978

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide

1 reference

https://pubmed.ncbi.nlm.nih.gov/15662978

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Malignant glioma--timing of response to radiation therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/15662978

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse

1 reference

https://pubmed.ncbi.nlm.nih.gov/15662978

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interobserver variability in the radiological assessment of response to chemotherapy in glioma

1 reference

https://pubmed.ncbi.nlm.nih.gov/15662978

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemotherapy response criteria in malignant glioma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15662978

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitation

1 reference

https://pubmed.ncbi.nlm.nih.gov/15662978

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: an analysis based on Surveillance, Epidemiology, and End Results (SEER) data, 1973-1991.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15662978

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro inactivation of human O6-alkylguanine DNA alkyltransferase by antitumor triazene compounds

1 reference

https://pubmed.ncbi.nlm.nih.gov/15662978

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The determinatio of the number of patients required in a preliminary and a follow-up trial of a new chemotherapeutic agent

1 reference

https://pubmed.ncbi.nlm.nih.gov/15662978

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase II study of preradiation chemotherapy followed by external beam radiotherapy for the treatment of patients with newly diagnosed glioblastoma multiforme: an Eastern Cooperative Oncology Group study (E2393).

1 reference

https://pubmed.ncbi.nlm.nih.gov/15662978

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase III study comparing three cycles of infusional carmustine and cisplatin followed by radiation therapy with radiation therapy and concurrent carmustine in patients with newly diagnosed supratentorial glioblastoma multiforme: Eastern Cooperative

1 reference

https://pubmed.ncbi.nlm.nih.gov/15662978

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11060-004-9175-1

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40516605&oldid=2203752185"